<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="95861">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02030756</url>
  </required_header>
  <id_info>
    <org_study_id>Vibrant-14-MS-CTIL</org_study_id>
    <nct_id>NCT02030756</nct_id>
  </id_info>
  <brief_title>Performance, Efficacy and Safety of Vibrating Capsule in Aiding Constipated Individuals</brief_title>
  <official_title>Assessment of the Performance, Efficacy and Safety of Vibrating Capsule Medical Device in Aiding Reliving Constipated Individuals.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Vibrant Ltd.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Vibrant Ltd.</source>
  <oversight_info>
    <authority>Israel: Ministry of Health</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a study intended to evaluate the efficacy and safety of the vibrating capsule versus
      sham non-vibrating capsule on spontaneous bowel movement, in aiding reliving Constipated
      Individuals
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>February 2014</start_date>
  <completion_date type="Anticipated">February 2015</completion_date>
  <primary_completion_date type="Anticipated">November 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Frequency of bowel movements</measure>
    <time_frame>3 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>change in the frequency of bowel movements - weekly Spontaneous Bowel Movement (SBM) rate -  from baseline to during treatment period</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Chronic Idiopathic Constipation</condition>
  <arm_group>
    <arm_group_label>Vibrating capsule</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>patients will receive vibrating capsule for 8 weeks of treatment (1 every 4 days).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>sham vibrating capsule</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>patients will receive sham vibrating capsule for 8 weeks of treatment (1 every 4 days).</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>vibrating capsule</intervention_name>
    <description>patients will receive vibrating capsule for 8 weeks of treatment (1 every 4 days).</description>
    <arm_group_label>Vibrating capsule</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>sham vibrating capsule</intervention_name>
    <description>patients will receive sham vibrating capsule for 8 weeks of treatment (1 every 4 days).</description>
    <arm_group_label>sham vibrating capsule</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Patients aged 18 years and older.

          2. Colonoscopy performed in the past 5 years prior to study participation, unless the
             patients are &lt;50 years old and without alarming signs and symptoms

          3. Patients with chronic idiopathic constipation according to Rome III  criteria and who
             have not experienced satisfactory relief of their symptoms from available therapies.

          4. Patients with more than 1 bowel movement/2 weeks and â‰¤3 bowel movement/week.

          5. Patient signed ICF

          6. For women with childbearing potential, adequate contraception

        Exclusion Criteria:

          1. History of complicated/obstructive diverticular disease

          2. History of intestinal or colonic obstruction.

          3. History of significant GI disorder.

          4. Use of following medication: Medication that may affect the bowel mobility,
             Prokinetics,  Anti-Depressants, medications for treatment of Parkinson disease,
             Opiates, Calcium-channel Blockers, Aluminium/Magnesium Hydroxids

          5. Clinical evidence of significant respiratory, CVS, renal, hepatic, biliary,
             endocrine, psychiatric, neurologic, or presence of abdominal pacemakers.

          6. Presence of pacemaker.

          7. History of, or current eating disorders, such as anorexia, bulimia, or compulsory
             overeating.

          8. Diagnosis of mega-rectum or colon, a history of intestinal obstruction, congenital
             anorectal malformation, clinically significant rectocele, or any evidence of
             intestinal structural abnormality, including GI resection that affects bowel transit,
             or any evidence of intestinal carcinoma or inflammatory bowel disease of alarm
             symptoms such as weight loss, rectal bleeding, or anaemia.

          9. Participation in another clinical study in the last 4 months prior to screening.

         10. Any other condition which in the opinion of the investigator may adversely affect the
             safety of the patient or would limit the patient's ability to complete the clinical
             study.

         11. Women who are pregnant or lactating. -
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Bat-Yamon</name>
      <address>
        <city>Bat Yam</city>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nimrod Kimchi, MD</last_name>
      <phone>972-3-5556559</phone>
      <email>TANimrodKi@clalit.org.il</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Souraski Medical Center</name>
      <address>
        <city>Tel Aviv</city>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ron Yishai, M.D.</last_name>
      <phone>972-3-6974463</phone>
      <email>yishair@tlvmc.gov.il</email>
    </contact>
    <investigator>
      <last_name>Ron Yishai, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>100 Tower</name>
      <address>
        <city>Tel Aviv</city>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eran Maoz, MD</last_name>
      <phone>972-3-7625245</phone>
      <email>EranMa@clalit.org.il</email>
    </contact>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>April 2014</verification_date>
  <lastchanged_date>April 23, 2014</lastchanged_date>
  <firstreceived_date>January 7, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>constipation</keyword>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>Yes</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Constipation</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
